Solutions Spotlight
Jacob Tesdorpf
Director High Content and Detection Instruments
PerkinElmer
Multicellular “oids” (tumoroids, spheroids, organoids) bear the potential to better predict drug candidate effects during preclinical screening. However, screening with 3D cell models is challenging and being able to effectively analyze them is still one of the main bottlenecks. Using 3D spheroids and cysts as examples, this presentation will show you how to better visualize and analyze 3D models during assay development and screening using new software tools.
These enable you to:
- Speed up 3D image acquisition by targeted imaging of objects of interest
- Better understand the spatial context of your 3D cell models through different visualization methods
- Measure volume and morphology changes in 3D
- Characterize spheroids in detail
- Export 3D movies to share and publish
High-Content Screening goes 3D: New tools for effective 3D visualization and analysis
Tuesday, February 6
10:30 AM – 10:50 AM
Tuesday, February 6
12:30 PM – 1:15 PM
Tuesday, February 6
2:00 PM – 2:45 PM
Tuesday, February 6
2:00 PM – 2:45 PM
Director High Content and Detection Instruments
PerkinElmer
As portfolio director for high content and detection instruments, Dr. Tesdorpf is leading the global product management and application development for high content screening and multimodal detection at PerkinElmer. He holds a doctorate in biochemistry from Hannover University and did research on nuclear hormone receptors at the Max-Planck-Institute. Dr. Tesdorpf held several imaging related sales and marketing roles at Molecular Dynamics, Amersham Biosciences and GE Healthcare looking after proteomics, microarrays, pre-clinical imaging and high content analysis. Prior to joining PerkinElmer in 2010 Dr. Tesdorpf headed the marketing group at 5 PRIME GmbH a supplier of nucleic acid purification and amplification products.
High-Content Screening goes 3D: New tools for effective 3D visualization and analysis
Tuesday, February 6
10:30 AM – 10:50 AM
The asset you are trying to access is locked. Please enter your access key to unlock.